Advertisement
Screener

ZYNERBA PHARMACEUTICALS, INC. Operating Cash Flow

ZYNERBA PHARMACEUTICALS, INC. Operating Cash Flow

ZYNERBA PHARMACEUTICALS, INC. reported Operating Cash Flow of -$16.30 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2023-08-14

  • ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2023-06-30 was -$8.42M.
  • ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2023-03-31 was -$7.88M, a 4027.73% decline year-over-year.
  • ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2022-12-31 was -$5.69M.
  • ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$9.66M.
  • ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$23.03M.
  • ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$33.46M.
  • ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$41.31M.
  • ZYNERBA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$34.82M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2023-06-30-$8.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$16.30M
10-Q · filed 2023-08-14
-$21.98M
derived: sum of 3 quarters · filed 2023-08-14
-$31.64M
derived: sum of 4 quarters · filed 2023-08-14
2023-03-31-$7.88M
10-Q · filed 2023-05-15
-$13.57M
derived: sum of 2 quarters · filed 2023-05-15
-$23.22M
derived: sum of 3 quarters · filed 2023-05-15
-$31.11M
derived: sum of 4 quarters · filed 2023-08-14
2022-12-31-$5.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
-$15.34M
derived: sum of 2 quarters · filed 2023-03-28
-$23.23M
derived: sum of 3 quarters · filed 2023-08-14
-$23.03M
10-K · filed 2023-03-28
2022-09-30-$9.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$17.54M
derived: sum of 2 quarters · filed 2023-08-14
-$17.34M
10-Q · filed 2022-11-14
-$25.18M
derived: sum of 4 quarters · filed 2023-08-14
2022-06-30-$7.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$7.68M
10-Q · filed 2023-08-14
-$15.52M
derived: sum of 3 quarters · filed 2023-08-14
-$25.56M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$200.63K
10-Q · filed 2023-05-15
-$7.63M
derived: sum of 2 quarters · filed 2023-05-15
-$17.68M
derived: sum of 3 quarters · filed 2023-05-15
-$24.96M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$7.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
-$17.88M
derived: sum of 2 quarters · filed 2023-03-28
-$25.16M
derived: sum of 3 quarters · filed 2023-03-28
-$33.46M
10-K · filed 2023-03-28
2021-09-30-$10.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$17.33M
derived: sum of 2 quarters · filed 2022-11-14
-$25.62M
10-Q · filed 2022-11-14
-$32.61M
derived: sum of 4 quarters · filed 2023-03-28
2021-06-30-$7.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
-$15.58M
10-Q · filed 2022-08-10
-$22.56M
derived: sum of 3 quarters · filed 2023-03-28
-$35.23M
derived: sum of 4 quarters · filed 2023-03-28
2021-03-31-$8.29M
10-Q · filed 2022-05-16
-$15.28M
derived: sum of 2 quarters · filed 2023-03-28
-$27.95M
derived: sum of 3 quarters · filed 2023-03-28
-$38.61M
derived: sum of 4 quarters · filed 2023-03-28
2020-12-31-$6.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
-$19.66M
derived: sum of 2 quarters · filed 2023-03-28
-$30.32M
derived: sum of 3 quarters · filed 2023-03-28
-$41.31M
10-K · filed 2023-03-28
2020-09-30-$12.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
-$23.33M
derived: sum of 2 quarters · filed 2021-11-15
-$34.33M
10-Q · filed 2021-11-15
-$41.79M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$10.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$21.66M
10-Q · filed 2021-08-09
-$29.12M
derived: sum of 3 quarters · filed 2022-03-01
-$40.11M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$11.00M
10-Q · filed 2021-05-12
-$18.46M
derived: sum of 2 quarters · filed 2022-03-01
-$29.45M
derived: sum of 3 quarters · filed 2022-03-01
-$36.30M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$7.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$18.45M
derived: sum of 2 quarters · filed 2022-03-01
-$25.30M
derived: sum of 3 quarters · filed 2022-03-01
-$34.82M
10-K · filed 2022-03-01
2019-09-30-$10.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$17.83M
derived: sum of 2 quarters · filed 2020-11-09
-$27.35M
10-Q · filed 2020-11-09
-$33.56M
derived: sum of 4 quarters · filed 2021-03-10
2019-06-30-$6.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$16.37M
10-Q · filed 2020-08-10
-$22.58M
derived: sum of 3 quarters · filed 2021-03-10
-$29.49M
derived: sum of 4 quarters · filed 2021-03-10
2019-03-31-$9.52M
10-Q · filed 2020-05-11
-$15.73M
derived: sum of 2 quarters · filed 2021-03-10
-$22.64M
derived: sum of 3 quarters · filed 2021-03-10
-$31.56M
derived: sum of 4 quarters · filed 2021-03-10
2018-12-31-$6.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10
-$13.12M
derived: sum of 2 quarters · filed 2021-03-10
-$22.04M
derived: sum of 3 quarters · filed 2021-03-10
-$32.40M
10-K · filed 2021-03-10
2018-09-30-$6.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
-$15.83M
derived: sum of 2 quarters · filed 2019-11-06
-$26.19M
10-Q · filed 2019-11-06
-$32.90M
derived: sum of 4 quarters · filed 2020-03-10
2018-06-30-$8.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$19.28M
10-Q · filed 2019-08-06
-$25.99M
derived: sum of 3 quarters · filed 2020-03-10
-$29.80M
derived: sum of 4 quarters · filed 2020-03-10
2018-03-31-$10.36M
10-Q · filed 2019-05-08
-$17.08M
derived: sum of 2 quarters · filed 2020-03-10
-$20.88M
derived: sum of 3 quarters · filed 2020-03-10
-$28.55M
derived: sum of 4 quarters · filed 2020-03-10
2017-12-31-$6.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
-$10.52M
derived: sum of 2 quarters · filed 2020-03-10
-$18.19M
derived: sum of 3 quarters · filed 2020-03-10
-$25.84M
10-K · filed 2020-03-10
2017-09-30-$3.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$11.48M
derived: sum of 2 quarters · filed 2018-11-08
-$19.13M
10-Q · filed 2018-11-08
-$24.64M
derived: sum of 4 quarters · filed 2019-03-11
2017-06-30-$7.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$15.32M
10-Q · filed 2018-08-02
-$20.83M
derived: sum of 3 quarters · filed 2019-03-11
-$26.41M
derived: sum of 4 quarters · filed 2019-03-11
2017-03-31-$7.65M
10-Q · filed 2018-05-08
-$13.16M
derived: sum of 2 quarters · filed 2019-03-11
-$18.74M
derived: sum of 3 quarters · filed 2019-03-11
-$23.41M
derived: sum of 4 quarters · filed 2019-03-11
2016-12-31-$5.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11
-$11.09M
derived: sum of 2 quarters · filed 2019-03-11
-$15.76M
derived: sum of 3 quarters · filed 2019-03-11
-$20.44M
10-K · filed 2019-03-11
2016-09-30-$5.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
-$10.26M
derived: sum of 2 quarters · filed 2017-11-14
-$14.93M
10-Q · filed 2017-11-14
-$18.13M
derived: sum of 4 quarters · filed 2018-03-12
2016-06-30-$4.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
-$9.35M
10-Q · filed 2017-08-01
-$12.55M
derived: sum of 3 quarters · filed 2018-03-12
-$15.65M
derived: sum of 4 quarters · filed 2018-03-12
2016-03-31-$4.67M
10-Q · filed 2016-05-12
-$7.87M
derived: sum of 2 quarters · filed 2018-03-12
-$10.97M
derived: sum of 3 quarters · filed 2018-03-12
-$12.55M
derived: sum of 4 quarters · filed 2018-03-12
2015-12-31-$3.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
-$6.30M
derived: sum of 2 quarters · filed 2018-03-12
-$7.87M
derived: sum of 3 quarters · filed 2018-03-12
-$9.79M
10-K · filed 2018-03-12
2015-09-30-$3.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
-$4.68M
derived: sum of 2 quarters · filed 2016-11-14
-$6.59M
10-Q · filed 2016-11-14
-$8.06M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30-$1.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
-$3.49M
10-Q · filed 2016-08-11
-$4.95M
derived: sum of 3 quarters · filed 2016-08-11
-$6.38M
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31-$1.92M
10-Q · filed 2016-05-12
-$3.38M
derived: sum of 2 quarters · filed 2016-05-12
-$4.81M
derived: sum of 3 quarters · filed 2016-05-12
2014-12-31-$1.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
-$2.89M
derived: sum of 2 quarters · filed 2016-03-14
-$3.54M
10-K · filed 2016-03-14
2014-09-30-$1.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
-$2.07M
10-Q · filed 2015-11-12
2014-06-30-$650.24K
10-Q · filed 2015-08-27
2013-12-31-$117.71K
10-K · filed 2016-03-14